Article Information
History
- February 11, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Marco Del Riccio1,*,
- Peter Spreeuwenberg1,
- Richard Osei-Yeboah3,
- Caroline K. Johannesen4,
- Liliana Vazquez Fernandez5,
- Anne C. Teirlinck6,
- Xin Wang7,
- Terho Heikkinen8,
- Mathieu Bangert9,
- Saverio Caini1,
- Harry Campbell3,
- John Paget1 and
- the RESCEU investigators
- 1Netherlands Institute for Health Services Research (Nivel), Utrecht, The Netherlands
- 2Department of Health Sciences, University of Florence, 50134 Florence, Italy
- 3Centre for Global Health, Usher Institute, University of Edinburgh
- 4Statens Serum Institut, Copenhagen, Denmark
- 5Department of Methods Development & Analytics, Norwegian Institute of Public Health, Oslo, Norway
- 6Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands
- 7School of Public Health, Nanjing Medical University, Nanjing, China
- 8Department of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland
- 9Sanofi Vaccines, Lyon, France
- ↵*Corresponding author; email: marco.delriccio{at}unifi.it